LabStyle Innovations Corp. announced that it has filed a Premarket Notification Application, also known as a 510(k), with the US Food and Drug Administration for the DarioBlood Glucose Monitoring System. The complete Dario diabetes management platform combines the aforementioned all-in-one, blood glucose monitoring system, a smart phone application, and a website application.

Dario is the complete diabetes management platform designed to empower people with diabetes to take charge of their health with the right tools, insights, and support, right in their pocket. With access to both real-time and historical blood glucose data, the Dario platform is designed to spot patterns, recommend the right treatments and support behavior change efforts. In the future, Dario will help doctors to better identify patients at high-risk, to make, more frequently, better and faster clinical decisions, and to more easily, routinely follow-up.

The Dario platform is also expanding to assist health systems in automatically targeting resources to patients who are most likely to have acute or long-term complications.